The activin receptor-like kinase 1 gene: Genomic structure and mutations in hereditary hemorrhagic telangiectasia type 2

American Journal of Human Genetics

Volumn 61, Issue 1, 1997, Pages 60-67

  Berg, Jonathan N ^a,b   Gallione, Carol J ^a   Stenzel, Timothy T ^a   Johnson, David W ^a   Allen, William P ^c   Schwartz, Charles E ^c   Jackson, Charles E ^d   Porteous, Mary E M ^b   Marchuk, Douglas A ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c GREENWOOD GENETIC CENTER   (United States)

^d HENRY FORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN; DNA; MESSENGER RNA; PROTEIN SERINE THREONINE KINASE;

AMINO ACID SEQUENCE; ARTICLE; AUTOSOMAL DOMINANT DISORDER; CHROMOSOME 12Q; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; GENE LOCUS; GENE MUTATION; GENE STRUCTURE; GENETIC LINKAGE; GENOME; HUMAN; HUMAN CELL; MUTATION RATE; PRIORITY JOURNAL; RECEPTOR GENE; RENDU OSLER WEBER DISEASE;

EID: 0030813490     PISSN: 00029297     EISSN: None     Source Type: Journal    
DOI: 10.1086/513903     Document Type: Article

References (33)

1. Attisano L, Carcamo J, Ventura F, Weis FMB, Massague J, Wrana JL (1993) Identification of human activin and TGF-β type I receptors that form heteromeric kinase complexes with type II receptors. Cell 75:671-680
2. Berg JN, Guttmacher AE, Marchuk DA, Porteous MEM (1996) Clinical heterogeneity in hereditary hemorrhagic telangiectasia: are pulmonary arteriovenous malformations more common in families linked to endoglin? J Med Genet 33:256-257
3. Braverman IM, Keh A, Jacobson BS (1990) Ultrastructure and three-dimensional organization of the telangiectases of hereditary hemorrhagic telangiectasia. J Invest Dermatol 95: 422-427
4. Cheifetz S, Bellon T, Cales C, Vera S, Bernabeu C, Massague J, Letarre M (1992) Endoglin is a component of the transforming growth factor-β receptor system in human endothelial cells. J Biol Chem 267:19027-19030
5. Ebner R, Chen RH, Shum L, Lawler S, Zioncheck TF, Lee A, Lopez AR, et al (1993) Cloning of a type I TGF-β receptor and its effect on TGF-β binding to the type II receptor. Science 260:344-348
6. Feng XH, Filvaroff EH, Derynck R (1995) Transforming growth factor-β (TGF-β)-induced down-regulation of cyclin A expression requires a functional TGF-β receptor complex. J Biol Chem 270:24237-24245
7. Guttmacher AE, Marchuk DA, White RI (1995) Current concepts: hereditary hemorrhagic telangiectasia. N Engl J Med 333:918-924
8. Gyapay G, Morissette J, Vignal A, Dib C, Fizames C, Millasseau P, Marc S, et al (1994) The 1993-94 Généthon human genetic linkage map. Nat Genet 7:246-339
9. Heutink P, Haitjema T, Breedveld GJ, Janssen B, Sandkuijl LA, Bontekoe CJM, Westerman CJJ, et al (1994) Linkage of hereditary hemorrhagic telangiectasia to chromosome 9q34 and evidence for locus heterogeneity. J Med Genet 31:933-936
10. Ioannou PA, Amemiya CT, Garnes J, Kroisel PM, Hiroaki S, Chen C, Batzer MA, et al (1994) A new bacteriophage P1-derived vector for the propagation of large human DNA fragments. Nat Genet 6:84-89
11. Johnson DW, Berg JN, Baldwin MA, Gallione CJ, Marondel I, Yoon SJ, Stenzel TT, et al (1996) Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2. Nat Genet 13:189-195
12. Johnson DW, Berg JN, Gallione CJ, McAllister KA, Warner JP, Helmbold EA, Markel DS, et al (1995) A second locus for Hereditary Hemorrhagic Telangiectasia maps to chromosome 12. Genome Res 5:21-28
13. Madri JA, Kocher O, Merwin JR, Bell L, Tucker A, Basson CT (1989) Interactions of vascular cells with transforming growth factor beta. Ann NY Acad Sci 593:243-258
14. Masakazu T, Akioka K, Yasuda M, Ikuno Y, Oku H, Takeuchi K, Takeda T (1988) Case report: hereditary hemorrhagic telangiectasia with growing pulmonary arteriovenous fistulas followed for 24 years. Am J Med Sci 295:545-547
15. McAllister KA, Baldwin MA, Thukkani AK, Gallione CJ, Berg JN, Porteous ME, Guttmacher AE, et al (1995) Six novel mutations in the endoglin gene in hereditary hemorrhagic telangiectasia type 1 suggest a dominant-negative effect of receptor function. Hum Mol Genet 4:1983-1985
16. McAllister KA, Grogg KM, Johnson DW, Gallione CJ, Baldwin MA, Jackson CE, Helmbold EA, et al (1994a) Endoglin, a TGF-β receptor of endothelial cells, is the gene for hereditary hemorrhagic telangiectasia type 1 (OWR1) Nat Genet 8:345-351
17. McAllister KA, Lennon F, Bowles-Biesecker B, McKinnon WC, Helmbold EA, Markel DS, Jackson CE, et al (1994b) Genetic heterogeneity in hereditary haemorrhagic telangiectasia: possible correlation with clinical phenotype. J Med Genet 31:927-932
18. McDonald MT, Papenberg KA, Ghosh S, Glatfelter AA, Biesecker BB, Helmbold EA, Markel DS, et al (1994) A disease locus for hereditary haemorrhagic telangiectasia maps to chromosome 9q33-34. Nat Genet 6:197-204
19. Merwin JR, Anderson J, Kocher O, van Itallie C, Madri JA (1990) Transforming growth factor β1 modulates extracellular matrix organization and cell-cell junctional complex formation during in vitro angiogenesis. J Cell Physiol 142: 117-128
20. Niehrs C (1996) Growth factors: mad connection to the nucleus. Nature 381:561-562
21. Piantanida M, Buscarini E, Dellavecchia C, Minelli A, Rossi A, Buscarini L, Danesino C (1996) Hereditary haemorrhagic telangiectasia with extensive liver involvement is not caused by either HHT1 or HHT2. J Med Genet 33:441-443
22. Plauchu H, de Chadarevian J-P, Bideau A, Robert J-M (1989) Age related clinical profile of hereditary hemorrhagic telangiectasia in an epidemiologically recruited population. Am J Med Genet 32:291-297
23. Porteous MEM, Curtis A, Williams O, Marchuk D, Bhattacharya SS, Burn J (1994) Genetic heterogeneity in hereditary haemorrhagic telangeiectasia. J Med Genet 31:925-926
24. Qian F, Watnick TJ, Onuchic LF, Germino GG (1996) The molecular basis of focal cyst formation in human autosomal dominant polycystic kidney disease type 1. Cell 87:979-987
25. Sambrook J, Fritsch EF, Maniatis T (1989) Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
26. Schmitt J, Mielke R, Schrewe H (1995) Genomic organization of a mouse type 1 activin receptor. Biochem Biophys Res Commun 213:211-217
27. Senapathy P, Shapiro MB, Harris NL (1990) Splice junctions, branch point sites, and exons: sequence statistics, identification, and applications to genome project. Methods Enzymol 183:252-278
28. Shovlin C, Hughes JMB, Tuddenham EGD, Temperley I, Perembelon YFN, Scott J, Seidman CE, et al (1994) A gene for hereditary hemorrhagic telangiectasia maps to chromosome 9q3. Nat Genet 6:205-209
29. ten Dijke P, Ichijo H, Franzen P, Schulz P, Saras J, Toyoshima H, Heldin CH, et al (1993) Activin receptor-like kinases: a novel subclass of cell-surface receptors with predicted serine/ threonine kinase activity. Oncogene 8:2879-2887
30. Vase P, Holm M, Arendrup H (1985) Pulmonary arteriovenous fistulas in hereditary hemorrhagic telangiectasia. Acta Med Scand 218:105-109
31. Vincent P, Plauchu H, Hazan J, Faure S, Weissenbach J, Godet J (1995) A third locus for hereditary haemorrhagic telangiectasia maps to chromosome 12q. Hum Mol Genet 4:945-949
32. Yamamoto H, Ueno H, Ooshima A, Takeshita A (1996) Adenovirus-mediated transfer of a truncated transforming growth factor-β (TGF-β) type II receptor completely and specifically abolishes diverse signaling by TGF-β in vascular wall cells in primary culture. J Biol Chem 271:16253-16259
33. Zhang Y, Feng XH, Wu RY, Derynck, R (1996) Receptor-associated Mad homologues synergize as effectors of the TGF-β response. Nature 383:168-172